BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
$2.375+0.025 (1.064%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.350
High
$2.380
Low
$2.300
Volume
0.56M
Company Fundamentals
Market Cap
135.0M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.50M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.195Current $2.375High $6.75
Related News
GlobeNewswire
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with best-in-class potential
View more
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $12
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and raises the price target from $11 to $12.
View more
Analyst Upgrades
Stifel Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $15
Stifel analyst Bradley Canino maintains Black Diamond Therapeutic with a Buy and lowers the price target from $16 to $15.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.